AstraZeneca AG - Iressa, Filmtabletten | | 56154 | | 01 | | Iressa | | Filmtabletten | | L01EB01 | | Gefitinib | | 02.03.2004 | | |
| Composition | gefitinibum 250 mg, lactosum monohydricum 163.5 mg, cellulosum microcristallinum, carmellosum natricum conexum, povidonum K 29-32, natrii laurilsulfas, magnesii stearas, Überzug: hypromellosum, macrogolum 300, E 171, E 172 (rubrum), E 172 (flavum), pro compresso obducto corresp. natrium 2.02 mg. | Packungsbestandteile | | Coated tablets | | | Active Agent | Dose |
---|
Gefitinib | 250 mg |
| BAG: Active Agent | Dose |
---|
Gefitinib | 250 mg |
| | Inactive agents | Dose | additional_information |
---|
(Flavum) | | | (Rubrum) | | | Carmellosum Natricum Conexum | | | Cellulosum Microcristallinum | | | E 171 | | color. | E 172 | | color. | Hypromellosum | | Überzug | Lactose Monohydrate | 163.5 mg | | Macrogol | 300 | | Magnesii Stearas | | | Natrii Laurilsulfas | | | Povidonum K | 29-32 | | Pro Compresso Obducto | | |
| |
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
---|
001 | 30 Tablet(s) | 2161.60 | 2367.30 | A | SL | Yes |
|
|